Library
  • Behind the Science
  • Science Innovation
    • Vapor
    • Modern Oral
    • Traditional Oral
  • Scientific Assessment
    • Emission Studies
    • Exposure Studies
    • Risk Studies
  • Science Engagement & Communication
    • Publications
    • Conferences
    • Our Scientists
  • Library
  • Behind the Science
  • Science Innovation
    • Vapor
    • Modern Oral
    • Traditional Oral
  • Scientific Assessment
    • Emission Studies
    • Exposure Studies
    • Risk Studies
  • Science Engagement & Communication
    • Publications
    • Conferences
    • Our Scientists
  • Library

Archives: Library

Identification and Quantitation of Nicotine Polacrilex in Nicotine Pouches and Other Oral Nicotine Delivery Products

June 16, 2023

By Cole Gibson

Part two: an unblinded, parallel, randomized study to assess nicotine pharmacokinetics of four Vuse Solo ENDS flavors in smokers

June 7, 2023

By Cole Gibson

Biomarkers of Exposure and Potential Harm in Two Weeks of Smoking Abstinence: Changes in Biomarkers of Platelet Function, Oxidative Stress, and Inflammation

April 10, 2023

By Cole Gibson

Two Techniques for the Analysis of WS-3 With Potential Application to the Analysis of Other Cooling Agents

April 6, 2023

By Cole Gibson

Key Challenges and Recommendations for In Vitro Testing of Tobacco Products for Regulatory Applications: Consideration of Test Materials and Exposure Parameters

March 27, 2023

By Cole Gibson

Partial Vapor Pressures, Activity Coefficients, Henry Volatility, and Infinite Dilution Activity Coefficients of Nicotine from Binary Mixtures with Glycerol and with 1,2-Propanediol at 298.15 K

March 7, 2023

By Cole Gibson

Comparison of two methods for ginsenosides quantitation

January 19, 2023

By Cole Gibson

Part one: abuse liability of Vuse Solo (G2) electronic nicotine delivery system relative to combustible cigarettes and nicotine gum

December 21, 2022

By Cole Gibson

Part three: a randomized study to assess biomarker changes in cigarette smokers switched to Vuse Solo or Abstinence

December 5, 2022

By Cole Gibson

Differential exposure biomarker levels among cigarette smokers and smokeless tobacco consumers in the National Health and Nutrition Examination Survey 1999–2008

November 9, 2022

By Cole Gibson

Posts navigation

Older posts
Newer posts
Science Innovation Scientific Assessment Science Engagement & Communication
Our Scientists Conferences Publications

This website is intended for scientists and policymakers. We encourage persons interested in tobacco harm reduction to consider all points of view and sources of information. Reynolds does not make health claims regarding its brands. Nothing contained here should be misconstrued to the contrary. To the extent that third-party sources are referenced, Reynolds is not responsible for the content of referenced sources and the views expressed may not represent the views of Reynolds. No tobacco product is safe, all tobacco products containing nicotine are addictive. Youth should never use tobacco. Smokers who are concerned about their health should quit.
Reynolds American Inc. is the U.S. parent company of, among others, R. J. Reynolds Tobacco Company; Santa Fe Natural Tobacco Company, Inc.; American Snuff Company, LLC; R. J. Reynolds Vapor Company; Modoral Brands Inc.; RAI Services Company; and Reynolds Marketing Services Company. All subsidiaries operate and conduct separate, distinct businesses. References to “Reynolds,” “the group,” “the company,” “we,” “us,” and “our” are simply for convenience and may be used to refer to Reynolds American Inc. and/or one of its independent subsidiary operating companies, collectively or individually, and are not intended to imply or suggest that the subsidiaries’ businesses are operated other than as separate, distinct businesses. Activities among affiliate companies are covered through intercompany services agreements with arm's-length terms and conditions.

© 2025 RAISC

Terms of Use Privacy Policy